Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration (Q84697393)
Jump to navigation
Jump to search
scientific article published on 01 January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration |
scientific article published on 01 January 2012 |
Statements
Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration (English)
Marcos P Avila
Michael E Farah
Arturo Santos
Livia Carla
Gildo Fuji
Juliana Rossi
1 January 2012